Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,714.00
(
-1.73%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
106.58
(
5.89%
)
Bitcoin
71,073.25
(
-3.88%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

microcapfun

Send PM Follow Ignore
Followers 6
Posts 560
Boards Moderated 0
Alias Born 03/13/2007

microcapfun

Re: DewDiligence post# 71789

Monday, 01/19/2009 8:12:12 PM

Monday, January 19, 2009 8:12:12 PM

Post# of 257257
>>Are the PK calculations you posted for genotype-2/3 patients, specifically? The numbers for genotype-2/3 might be different from genotype-1, and this could explain why NVS/HGSI are pursuing monthly dosing for genotype-2/3 only.<<

I was assuming the in vivo half life was independent of genotype, but as you point out, that might be an incorrect assumption.

micro

Life is an IQ test.

email: microcapfun@yahoo.com

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now